11/07/24
industry:
Cell therapy
company:
Sana Biotechnology
job rating:
1 - I hate my job
Layoffs are coming. Some from the top have to go too.
11/03/24
industry:
Cell therapy
company:
Sana Biotechnology
job rating:
1 - I hate my job
Money for less than a year and no revenue. Risky. Top heavy, all important connected persons, but few performers. Stock tanked. No prospects.
01/29/24
industry:
Cell therapy
company:
Kite Pharma
job rating:
1 - I hate my job
New CEO came from Roche and quickly decided to lay off staff. Gilead had no understanding of cell therapy and Roche person does not bring such experience. CAR T therapy at Kite was in trouble already under previous CEO. Now the CAR T therapy is facing multiple headwinds, so difficulties for Kite and Gilead have amplified. Th easiest solution is to layoff staff. Layoffs started in 2023 and will continue beyond the original announced number. Bad prospects for Kite and Gilead. New CEO would not help much.
10/15/23
industry:
Cell therapy
company:
Sana Biotechnology
job rating:
1 - I hate my job
Top management heavy. At lower levels not so. Lacks expertise Burn rate high
01/19/23
industry:
Cell therapy
company:
Genenetech
job rating:
7 - I love my job
Great environment

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.